Cranbury, NJ, United States of America

Preeti Sejwal

This inventor holds 1 USPTO granted patent. Top assignee: Syracuse University. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Preeti Sejwal. Retrieved from https://idiyas.com/inventor/preeti-sejwal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Preeti Sejwal and Protein-Stabilization Innovation.

Introduction

Preeti Sejwal is an inventor associated with Syracuse University and based in Cranbury, New Jersey. Her patent work addresses protein aggregation, a challenge that can affect the stability and performance of protein-based medicines.

Latest Patents

Sejwal is named on 1 patent, titled “Method of Covalently Modifying Proteins with Organic Molecules to Prevent Aggregation.” The invention describes covalently modifying proteins with organic molecules, including sugar alcohols and cyclodextrins, while preserving their native folding. It uses water-driven bioorganic reactions designed to modify lysine or cysteine residues under physiological conditions. The proposed approach may reduce aggregation and enzymatic degradation while extending the time protein drugs remain in the bloodstream.

Career Highlights

Sejwal’s patent reflects research into methods for improving the stability and potential efficacy of protein drugs and antibodies. The disclosed approach explores the use of non-natural sugar alcohols and other small molecules to modify proteins.

Collaborations

The supplied information lists Debjyoti Bandyopadhyay and Deepali Prashar as Sejwal’s coworkers. Her work is associated with Syracuse University.

Conclusion

Preeti Sejwal’s patented method explores covalent protein modification as a way to address aggregation and support the development of more stable protein-based therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…